Navigation Links
Skin Integrity Products (SIP): Effective Distribution Networks Are Key to Penetrating Western European Market, Says Frost & Sullivan
Date:11/21/2012

LONDON, Nov. 21, 2012 /PRNewswire/ -- Skin integrity products (SIP) offer undeniable advantages to hospitals, healthcare workers (HCW) and populations at high risk for skin breakdown. Advantages include cost and time saving, improved operational efficiency and enhanced quality of life for affected individuals.

New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Skin Integrity Products Market in Western Europe, finds that the market earned revenues of $428.8 million in 2011 and estimates this to reach $605.1 million in 2018. The research covers cleansers, moisturizers and moisture barriers, adhesive removers and odour control segments.

A rapidly ageing population pool is expanding the applicable customer base for SIP. The increasing incidence of bowel cancer as well as of pressure ulcers and dermatitis is also driving the uptake of SIP products.

"Currently, the majority of product sales in the SIP market is direct – online and mail order sales," notes Frost & Sullivan Industry Analyst Beulah Devadason. "Though skin integrity products are used in hospitals, a large portion of the customer base is made up of community care settings and home users."

In order to effectively penetrate the western European SIP market, companies need to have an extensive and dependable logistics solution in terms of direct distribution or third party distribution. Manufacturers have to invest in direct distribution to keep costs down and meet the business requirements of the installed customer base in the best possible way. This has posed a significant entry barrier for non-European manufacturers.

"The logistics of direct sales and established distribution networks are the key competitive factors for manufacturers in this market," explains Devadason. "They have responded to this challenge through the adoption of several strategies, including the strengthening and expansion of their distribution networks."

Varied government policies related to reimbursement, prescription requirements, and CE mark requirements, have further contributed to the challenges of non-European competitors entering the market.

In addition, high entry barriers for non-European manufacturers have, interestingly, had a detrimental effect on local manufacturers. Limited competition has stunted market growth, even while dampening aggressive marketing and awareness raising activities.

"Aggressive marketing and proactive product promotion will encourage patients to explore all available solutions," advises Devadason. "Product innovation will be necessary to accelerate market growth."

If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com.

Skin Integrity Products Market in Western Europe is part of the Advanced Medical Technologies Growth Partnership Service programme, which also includes research in the following markets: Custom Procedure Trays and Packs Move Towards Standardisation, Western European Patient Prepping Products Market and Hand Hygiene Champions the Cause of Infection Control. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion
Join Us:           Join our community
Subscribe:       Newsletter on "the next big thing"
Register:         Gain access to visionary innovation

Contact
Anna Zanchi
Corporate Communications – Europe
P: 0039 02 46514819
E: anna.zanchi@frost.com
http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Verizon to Detail Health Care Fraud, Waste & Abuse - The Next Generation at National Association for Medicaid Program Integrity 2012 Conference, Sept. 18
2. Integrity Life Sciences Releases Corporate Resume
3. Health Revenue Assurance Associates Hires Valerie Rinkle as Vice President of Revenue Integrity Informatics
4. Integrity Life Sciences Expands Orthotic Options for Domestic and International Customers
5. Integrity Life Sciences Announces Two US Patents
6. Integrity Life Sciences Receives CE Mark and ISO Certifications for the Integrity Spinal Care System Medical Device
7. Kimberly-Clark Health Care Receives FDA Clearance For KIMGUARD ONE-STEP Sterilization Wrap Portfolio With One-Year Maintenance Of Package Integrity And Amsco V-PRO maX (Flexible Cycle)
8. Integrity Life Sciences Receives US FDA 510(k) Clearance for its Integrity Spinal Care System Medical Device
9. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
10. China Biologic Products, Inc. Adopts Stockholder Rights Plan
11. MEI Pharmas Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a program ... delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in ... and decide to donate. , “Women’s Hospital at Renaissance has been a collection ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... 2017 , ... Bill Howe started his sewer and drain company in 1980 ... joined the team, the Bill Howe brand was born and they began cultivating their ... back to the San Diego community in which they worked, lived and were raising ...
Breaking Medicine News(10 mins):